Editorial Commentary
The TROP2 paradox: enhancing precision in immunotherapy for advanced non-small cell lung cancer patients—a commentary
Translational Cancer Research
2025;
14
(2)
:660-666
.
(28 February 2025)
To be or low TMB (tumor mutational burden)
Translational Cancer Research
2025;
14
(2)
:667-669
.
(28 February 2025)
Osimertinib for uncommon EGFR mutations: herding UNICORNs in a field of horses
Translational Cancer Research
2025;
14
(2)
:670-675
.
(28 February 2025)
Accelerated hypofractionated chemoradiation followed by stereotactic ablative radiotherapy boost for locally advanced, unresectable non-small cell lung cancer
Translational Cancer Research
2025;
14
(2)
:676-678
.
(28 February 2025)
Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road
Translational Cancer Research
2025;
14
(2)
:679-684
.
(28 February 2025)
Original Article
Prognostic significance of alterations in peripheral cellular and humoral immune biomarkers during radiochemotherapy in head and neck cancer patients
Translational Cancer Research
2025;
14
(2)
:685-705
.
(28 February 2025)
Construction and validation of machine learning models for predicting lymph node metastasis in cutaneous malignant melanoma: a large population-based study
Translational Cancer Research
2025;
14
(2)
:706-716
.
(28 February 2025)
Expression profile, regulatory mechanism and prognostic potential of MBNL2 in esophageal squamous cell carcinoma
Translational Cancer Research
2025;
14
(2)
:717-730
.
(28 February 2025)
Radiomics models using machine learning algorithms to differentiate the primary focus of brain metastasis
Translational Cancer Research
2025;
14
(2)
:731-742
.
(28 February 2025)
Development and validation of a prognosis prediction model for overall survival in correlation between butyrate metabolism and gastric cancer prognosis: Mendelian randomization and transcriptomics analysis
Translational Cancer Research
2025;
14
(2)
:743-760
.
(28 February 2025)
Construction and validation of a prognostic model of lncRNAs associated with RNA methylation in lung adenocarcinoma
Translational Cancer Research
2025;
14
(2)
:761-777
.
(28 February 2025)
Specific effects of hypoxia-immune core gene ARHGAP11A on lung adenocarcinoma
Translational Cancer Research
2025;
14
(2)
:778-795
.
(28 February 2025)
Talin1 Ser425 phosphorylation promotes colorectal cancer progression and metastasis
Translational Cancer Research
2025;
14
(2)
:796-807
.
(28 February 2025)
Nomogram for predicting survival in breast cancer with lung metastasis based on SEER data
Translational Cancer Research
2025;
14
(2)
:808-826
.
(28 February 2025)
FUT10 is related to the poor prognosis and immune infiltration in clear cell renal cell carcinoma
Translational Cancer Research
2025;
14
(2)
:827-842
.
(28 February 2025)
Identification of Fanconi anemia pathway genes as novel prognostic biomarkers and therapeutic targets for breast cancer
Translational Cancer Research
2025;
14
(2)
:843-864
.
(28 February 2025)
CD69 predicts prognosis through immune cell infiltration and decitabine treatment response in acute myeloid leukemia
Translational Cancer Research
2025;
14
(2)
:865-880
.
(28 February 2025)
Diagnostics and immunological function of CENPN in human tumors: from pan-cancer analysis to validation in breast cancer
Translational Cancer Research
2025;
14
(2)
:881-906
.
(28 February 2025)
Characterization of immune landscape and prognostic value of IL-17-related signature in invasive breast cancer
Translational Cancer Research
2025;
14
(2)
:907-929
.
(28 February 2025)
Construction of a prognostic model and analysis of related mechanisms in breast cancer based on multiple datasets
Translational Cancer Research
2025;
14
(2)
:930-948
.
(28 February 2025)
A novel necroptosis-related miRNA signature for predicting the prognosis of esophageal cancer and immune infiltration analysis
Translational Cancer Research
2025;
14
(2)
:949-965
.
(28 February 2025)
A prognostic model for laryngeal squamous cell carcinoma based on the mitochondrial metabolism-related genes
Translational Cancer Research
2025;
14
(2)
:966-979
.
(28 February 2025)
The prognostic significance of fragile X mental retardation syndrome-related protein 1 (FXR1) in breast cancer
Translational Cancer Research
2025;
14
(2)
:980-989
.
(28 February 2025)
Analysis of risk and prognostic factors for pulmonary metastasis in gastric cancer: a study based on the Surveillance, Epidemiology, and End Results database
Translational Cancer Research
2025;
14
(2)
:990-1007
.
(28 February 2025)
The prognostic and immune significance of SNHG3 in clear cell renal cell carcinoma
Translational Cancer Research
2025;
14
(2)
:1008-1023
.
(28 February 2025)
The screening of optimal primary tumor resection candidates in patients with small cell lung cancer: a population-based predictive model
Translational Cancer Research
2025;
14
(2)
:1024-1036
.
(28 February 2025)
Mitochondrial permeability transition drives the expression, identification and validation of necrosis-related genes in prognostic risk models of hepatocellular carcinoma
Translational Cancer Research
2025;
14
(2)
:1037-1052
.
(28 February 2025)
Constructing and validating a novel prognostic risk score model for rectal cancer based on four immune-related genes
Translational Cancer Research
2025;
14
(2)
:1053-1069
.
(28 February 2025)
Oncogenic role and prognostic significance of PIMREG in melanoma
Translational Cancer Research
2025;
14
(2)
:1070-1084
.
(28 February 2025)
Comprehensive analysis of the immunological implication and prognostic value of MEAK7 in non-small cell lung cancer
Translational Cancer Research
2025;
14
(2)
:1085-1100
.
(28 February 2025)
The causal effects of 2,821 protein level ratios on non-small cell lung cancer: a two-sample Mendelian randomization study
Translational Cancer Research
2025;
14
(2)
:1101-1110
.
(28 February 2025)
Clinical characterization and prognostic modeling of bladder cancer patients with a history of prior tumors: a SEER database analysis
Translational Cancer Research
2025;
14
(2)
:1111-1123
.
(28 February 2025)
PRSS3 is a potential prognostic biomarker for lung adenocarcinoma
Translational Cancer Research
2025;
14
(2)
:1124-1140
.
(28 February 2025)
OPN3 enhances the proliferation, migration, and invasion of triple-negative breast cancer cells via the regulation of the TGF-β signaling pathway
Translational Cancer Research
2025;
14
(2)
:1141-1156
.
(28 February 2025)
Construction and validation of a cell death-related genes prognosis signature of hepatocellular carcinoma
Translational Cancer Research
2025;
14
(2)
:1157-1170
.
(28 February 2025)
FAM60A promotes proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin signaling pathway
Translational Cancer Research
2025;
14
(2)
:1171-1189
.
(28 February 2025)
Construction of a prognostic signature for breast cancer based on genes involved in unsaturated fatty acid biosynthesis
Translational Cancer Research
2025;
14
(2)
:1190-1204
.
(28 February 2025)
Circulating white blood cell traits, chemokines and small cell lung cancer risk: a Mendelian randomization study
Translational Cancer Research
2025;
14
(2)
:1205-1213
.
(28 February 2025)
Establishment of a prognosis-related predictive model for hepatocellular carcinoma patients with macrovascular invasion treated with transcatheter arterial chemoembolization combined with intensity modulated radiotherapy
Translational Cancer Research
2025;
14
(2)
:1214-1222
.
(28 February 2025)
Vanillic acid inhibits TGF-β type I receptor to protect bone marrow mesenchymal stem cells from radiation-induced bystander effects
Translational Cancer Research
2025;
14
(2)
:1223-1236
.
(28 February 2025)
Diagnostic accuracy of pleural fluid carbohydrate antigen 72-4 for malignant pleural effusion: a systematic review and meta-analysis
Translational Cancer Research
2025;
14
(2)
:1237-1245
.
(28 February 2025)
ATP5A1 as a potential prognostic biomarker in clear-cell renal cell carcinoma
Translational Cancer Research
2025;
14
(2)
:1246-1264
.
(28 February 2025)
Role of cancer stem cell heterogeneity in intrahepatic cholangiocarcinoma
Translational Cancer Research
2025;
14
(2)
:1265-1281
.
(28 February 2025)
Comprehensive bioinformatics analysis of co-mutation of FLG2 and TP53 reveals prognostic effect and influences on the immune infiltration in ovarian serous cystadenocarcinoma
Translational Cancer Research
2025;
14
(2)
:1282-1296
.
(28 February 2025)
High-sensitivity modified Glasgow prognostic score (HS-mGPS) is a prognostic biomarker for small duct-type intrahepatic cholangiocarcinoma—a retrospective cohort study
Translational Cancer Research
2025;
14
(2)
:1297-1310
.
(28 February 2025)
Total Astragalus saponins promote ferroptosis in gastric cancer cells by upregulating SIRT3
Translational Cancer Research
2025;
14
(2)
:1311-1322
.
(28 February 2025)
CALD1 inhibits invasion of human ovarian cancer cells by affecting cytoskeletal structure and the number of focal adhesion
Translational Cancer Research
2025;
14
(2)
:1323-1335
.
(28 February 2025)
Enhancing prognostic accuracy in invasive breast cancer by combining contrast-enhanced ultrasound and clinical data: a multicenter retrospective study
Translational Cancer Research
2025;
14
(2)
:1336-1358
.
(28 February 2025)
A novel machine learning-driven immunogenic cell death signature for predicting ovarian cancer prognosis
Translational Cancer Research
2025;
14
(2)
:1359-1374
.
(28 February 2025)
The miR-155-5p/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway
Translational Cancer Research
2025;
14
(2)
:1375-1387
.
(28 February 2025)
Androgen receptor expression distribution characteristics in young female breast cancer patients in China: a study of clinicopathological features
Translational Cancer Research
2025;
14
(2)
:1388-1400
.
(28 February 2025)
The efficacy and safety of the addition of programmed cell death protein 1 inhibitor to preoperative chemotherapy in locoregionally advanced oropharyngeal carcinoma
Translational Cancer Research
2025;
14
(2)
:1401-1414
.
(28 February 2025)
Low expression of PRTN3 regulates the progression of gastric cancer by inhibition of cell cycle and promotion of apoptosis
Translational Cancer Research
2025;
14
(2)
:1415-1427
.
(28 February 2025)
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer
Translational Cancer Research
2025;
14
(2)
:1428-1446
.
(28 February 2025)
Review Article
The emerging role of transmembrane proteins in tumorigenesis and therapy
Translational Cancer Research
2025;
14
(2)
:1447-1466
.
(28 February 2025)
Cryoablation for breast cancer: a narrative review of advances, clinical applications, and future challenges
Translational Cancer Research
2025;
14
(2)
:1467-1478
.
(28 February 2025)
Narrative review of 3D bioprinting for the construction of in vitro tumor models: present and prospects
Translational Cancer Research
2025;
14
(2)
:1479-1491
.
(28 February 2025)
Case Report: iMDT Corner
A rare case report of colon metastasis from primary oropharyngeal squamous cell carcinoma treated with a combination of surgery, radiotherapy and immunotargeted therapy
Translational Cancer Research
2025;
14
(2)
:1492-1499
.
(28 February 2025)
Amyopathic dermatomyositis associated with immune checkpoint inhibitor therapy in lung adenocarcinoma: a case report
Translational Cancer Research
2025;
14
(2)
:1500-1505
.
(28 February 2025)
Erratum
Erratum: Beclin-1 expression serves as an important biomarker for carcinogenesis and evolution in lung adenocarcinoma presenting as ground glass opacity
Translational Cancer Research
2025;
14
(2)
:1506
.
(28 February 2025)
